Please use this identifier to cite or link to this item:
|Title:||BrightOcular® Cosmetic Iris Implant: A Spectrum from Tolerability to Severe Morbidity||Authors:||Koaik, Mona K.
Mansour, Ahmad M.
Farah, Samir G.
|Affiliations:||Faculty of Medicine||Keywords:||BrightOcular® iris implant
Cosmetic iris implants
|Issue Date:||2018||Publisher:||National Library of Medicine||Part of:||Case Reports in Ophthalmology||Volume:||9||Issue:||2||Start page:||395||End page:||400||Abstract:||
Purpose: The BrightOcular® implants are the newest model of cosmetic iris devices that are currently advertised as safe. The previous generation known as NewColorIris® have had severe ocular side effects and were subsequently withdrawn from the market. There is little literature on the safety profile of BrightOcular® implants. Case Report: Herein we describe two cases with varying degrees of ocular tolerability. The first case had a normal ocular exam 1 year after implantation, whereas the second case had unilateral severe corneal edema requiring explantation of the iris device and Descemet membrane endothelial keratoplasty 9 months after bilateral implantation. Conclusions: These two cases attest to the unpredictability of the results of these cosmetic surgeries. Patients should be counseled about the vision-threatening complications of iris implants.
|URI:||https://scholarhub.balamand.edu.lb/handle/uob/5725||DOI:||10.1159/000492745||Open URL:||Link to full text||Type:||Journal Article|
|Appears in Collections:||Faculty of Medicine|
Show full item record
checked on Jul 2, 2022
checked on Jul 3, 2022
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.